Home Medical Encyclopedia Disease P Primary or secondary fibrinolysis

Primary or secondary fibrinolysis

Alternative Names: Fibrinolysis

Fibrinolysis is a normal body process that keeps naturally occurring blood clots from growing and causing problems.

Primary fibrinolysis refers to the normal breakdown of clots.

Secondary fibrinolysis is the breakdown of blood clots due to a medical disorder, medicine, or other cause.

Causes of Primary or secondary fibrinolysis

Blood clots form on a protein called fibrin. The breakdown of fibrin (fibrinolysis) can increase under certain conditions, such as:

  • Bacterial infections
  • Intense exercise
  • Low blood sugar
  • Not enough oxygen to tissues

In some situations, doctors may wish to speed up the rate of fibrinolysis. For example, when an abnormal clot forms in the blood vessels of the heart and results in a heart attack, human-made fibrinolytic substances (such as tPA, streptokinase, or Retavase) may be given to break up the clot.

Schafer AI. Hemorrhagic disorders: Disseminated intravascular coagulation, liver failure, and vitamin K deficiency. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 181.

Related Images

Learn more about Primary or secondary fibrinolysis

Review Date: 2/5/2010
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Do not use this information for medical emergencies - Call 911. This information should not be used for the diagnosis or treatment of any medical condition. A licensed medical practitioner should always be consulted for diagnosis and treatment of any and all medical conditions. Links to other websites do not constitute endorsements and are provided for information only. Any duplication or distribution of this information is strictly prohibited.
Copyright 2011 A.D.A.M., Inc.
(web5)